CA2326002A1 - Proteines de chlamydia et leurs utilisations - Google Patents

Proteines de chlamydia et leurs utilisations Download PDF

Info

Publication number
CA2326002A1
CA2326002A1 CA002326002A CA2326002A CA2326002A1 CA 2326002 A1 CA2326002 A1 CA 2326002A1 CA 002326002 A CA002326002 A CA 002326002A CA 2326002 A CA2326002 A CA 2326002A CA 2326002 A1 CA2326002 A1 CA 2326002A1
Authority
CA
Canada
Prior art keywords
seq
leu
chlamydia
infection
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002326002A
Other languages
English (en)
Inventor
Daniel D. Rockey
John P. Bannantine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon State Board of Higher Education
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2326002A1 publication Critical patent/CA2326002A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Certaines protéines de Chlamydia, qui sont apparues comme spécifiques d'une infection, sont également apparues comme principalement associées à la forme végétative à Corps Réticulé de Chlamydia plutôt qu'à la forme réfractile à Corps Elémentaire de Chlamydia. L'invention concerne en l'occurrence un vaccin contre la forme à Corps Réticulé de Chlamydia comprenant tout ou partie d'une ou deplusieurs protéines spécifiques de l'infection. L'invention concerne également, non seulement un mode d'utilisation d'un tel vaccin, mais aussi un procédé de production d'un tel vaccin, et un procédé de détection d'anticorps spécifiques de l'infection dans un échantillon biologique. L'invention concerne en outre un procédé de détection d'antigènes spécifiques de l'infection dans un échantillon biologique, ainsi qu'un mode d'emploi d'agents thérapeutiques spécifiquement dirigés contre des peptides spécifiques de l'infection, ou de gènes codant pour de tels peptides, et ce, pour traiter l'infection par Chlamydia. L'invention concerne enfin, d'une part les protéines IncB et IncC de C. psittaci, ainsi que des nucléotides codant ces protéines, et d'autre part les protéines TroA, TroB et p242 de ainsi que les nucléotides qui codent ces polypeptides.
CA002326002A 1998-04-20 1999-04-20 Proteines de chlamydia et leurs utilisations Abandoned CA2326002A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8243898P 1998-04-20 1998-04-20
US60/082,438 1998-04-20
US8258898P 1998-04-21 1998-04-21
US60/082,588 1998-04-21
US8645098P 1998-05-22 1998-05-22
US60/086,450 1998-05-22
PCT/US1999/008744 WO1999053948A1 (fr) 1998-04-20 1999-04-20 Proteines de chlamydia et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2326002A1 true CA2326002A1 (fr) 1999-10-28

Family

ID=27374277

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002326002A Abandoned CA2326002A1 (fr) 1998-04-20 1999-04-20 Proteines de chlamydia et leurs utilisations

Country Status (4)

Country Link
EP (1) EP1073458A4 (fr)
AU (1) AU754122B2 (fr)
CA (1) CA2326002A1 (fr)
WO (1) WO1999053948A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374059B2 (en) 2001-10-05 2008-05-20 Industrial And Environmental Concepts, Inc. Covering systems and venting methods
US9591797B2 (en) 2013-11-14 2017-03-14 Industrial & Environmental Concepts, Inc. Cover systems with fusion welds
US11141952B2 (en) 2015-04-06 2021-10-12 Industrial & Environmental Concepts, Inc. Sludge covers, sludge management systems, and related methods

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7811592B2 (en) 2000-08-16 2010-10-12 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
AU2002241642A1 (en) * 2000-12-15 2002-06-24 Auburn University Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia)
US20070149474A1 (en) 2000-12-15 2007-06-28 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
US8206724B2 (en) 2000-12-15 2012-06-26 Auburn University Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
US20030185848A1 (en) * 2000-12-15 2003-10-02 Board Of Regents, The University Of Texas System Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia psittaci
AU2002232118A1 (en) * 2002-02-11 2003-09-04 Secretary, Department Of Atomic Energy A method of pcr based detection and identification of rice blast fungus magnaporthe grisea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100735653B1 (ko) * 1997-11-28 2007-07-06 세로노 제네틱스 인스티튜트 에스.에이. 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
AU769293B2 (en) * 1998-12-08 2004-01-22 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374059B2 (en) 2001-10-05 2008-05-20 Industrial And Environmental Concepts, Inc. Covering systems and venting methods
US9591797B2 (en) 2013-11-14 2017-03-14 Industrial & Environmental Concepts, Inc. Cover systems with fusion welds
US11141952B2 (en) 2015-04-06 2021-10-12 Industrial & Environmental Concepts, Inc. Sludge covers, sludge management systems, and related methods

Also Published As

Publication number Publication date
EP1073458A4 (fr) 2005-01-12
AU754122B2 (en) 2002-11-07
WO1999053948A1 (fr) 1999-10-28
AU3659099A (en) 1999-11-08
EP1073458A1 (fr) 2001-02-07

Similar Documents

Publication Publication Date Title
CA2373021A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
EP0756630B1 (fr) Proteine a codage plasmidique de recombinaison pgp3, methodes de preparation et d'utilisation en diagnostic et en therapie
US7244613B2 (en) Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
JP2003510050A (ja) クラミジア抗原および対応するｄｎａ断片ならびにその使用
JP3440221B2 (ja) アクチノバチルス・プレウロニウモニアからのタンパク質
CA2408199A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisations de tels antigenes
WO1995028487A9 (fr) Proteine a codage plasmidique de recombinaison pgp3, methodes de preparation et d'utilisation en diagnostic et en therapie
CA2294651A1 (fr) Nouvelles proteines de membrane externe issues de chlamydia pneumoniae
CA2326002A1 (fr) Proteines de chlamydia et leurs utilisations
JP2002531093A (ja) クラミジア抗原および対応するｄｎａ断片ならびにその使用
EP2447278B1 (fr) Nouvelles protéines immunogènes de Leptospira
CA2190359C (fr) Acides nucleiques de rochalimaea henselae et de rochalimaea quintana et procedes et composition pour le diagnostic de l'infection par rochalimaea henselae et rochalimaea quintana
CA2516971A1 (fr) Polypeptides de chlamydia secretes, polynucleotides codant pour ceux-ci et utilisations therapeutiques et diagnostiques de ceux-ci
MXPA01009256A (es) Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
US6746676B1 (en) Chlamydia proteins and their uses
US6406887B1 (en) Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection
EP2363407A1 (fr) Nouvelles séquences de Brachyspira, compositions immunogènes, procédés pour leur préparation et utilisation
WO1999041614A2 (fr) Procedes
EP1140998B1 (fr) Antigenes a chlamydia, fragments d'adn correspondants et leurs utilisations
EP0915977A1 (fr) Polypeptides du type b. burgdorferi exprimes in vivo
JP2003512017A (ja) クラミジア抗原および対応するｄｎａ断片ならびにその使用
CA2352759A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation
WO2000062069A1 (fr) Technique permettant de detecter des micro-organismes exprimant l'intimine
CA2296869A1 (fr) Une lipoproteine a surface exposee de campylobacter jejuni participant a l'adhesion aux cellules hep-2
MXPA99009688A (en) New proteins of antinobacillus pleuropneumon

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued